135 related articles for article (PubMed ID: 1661764)
1. Inhibition of angiotensin converting enzyme by ramipril in serum and tissue of man.
Erman A; Winkler J; Chen-Gal B; Rabinov M; Zelykovski A; Tadjer S; Shmueli J; Levi E; Akbary A; Rosenfeld JB
J Hypertens; 1991 Nov; 9(11):1057-62. PubMed ID: 1661764
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamic effects of a single 10-mg dose of the angiotensin converting enzyme inhibitor ramipril in patients with impaired renal function.
Ocón-Pujadas J; Debusmann ER; Jane F; Lahn W; Irmisch R; Mora J; Grötsch H
J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S45-8. PubMed ID: 2474101
[TBL] [Abstract][Full Text] [Related]
3. Human intestinal brush border angiotensin-converting enzyme activity and its inhibition by antihypertensive Ramipril.
Stevens BR; Fernandez A; Kneer C; Cerda JJ; Phillips MI; Woodward ER
Gastroenterology; 1988 Apr; 94(4):942-7. PubMed ID: 2831105
[TBL] [Abstract][Full Text] [Related]
4. Physicochemical and enzyme binding kinetic properties of a new angiotensin-converting enzyme inhibitor ramipril and their clinical implications.
Bender N; Rangoonwala B; Rosenthal J; Vasmant D
Clin Physiol Biochem; 1990; 8 Suppl 1():44-52. PubMed ID: 2147879
[TBL] [Abstract][Full Text] [Related]
5. Effect of angiotensin-converting enzyme inhibition on human tissue renin.
Rosenthal J; Buehler G; Koenig W; Rangoonwala B
J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S122-4. PubMed ID: 1725019
[TBL] [Abstract][Full Text] [Related]
6. Acute and chronic in vivo inhibition of angiotensin-converting enzyme by perindopril in the endothelium and adventitia of large arteries and organs of the rabbit.
Zhuo J; Casley D; Murone C; Mendelsohn FA
J Cardiovasc Pharmacol; 1997 Mar; 29(3):297-310. PubMed ID: 9125666
[TBL] [Abstract][Full Text] [Related]
7. Effects of chronic converting enzyme inhibition on the vascular renin-angiotensin system.
Saito H; Nakamaru M; Rakugi H; Mikami H; Ogihara T; Inagami T
Clin Exp Pharmacol Physiol; 1990 Nov; 17(11):745-53. PubMed ID: 2150362
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of the vasopeptidase inhibitor AVE7688 in humans.
Azizi M; Bissery A; Peyrard S; Guyene TT; Ozoux ML; Floch A; Ménard J
Clin Pharmacol Ther; 2006 Jan; 79(1):49-61. PubMed ID: 16413241
[TBL] [Abstract][Full Text] [Related]
9. Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).
Cushman DW; Wang FL; Fung WC; Grover GJ; Harvey CM; Scalese RJ; Mitch SL; DeForrest JM
Br J Clin Pharmacol; 1989; 28 Suppl 2(Suppl 2):115S-130S; discussion 130S-131S. PubMed ID: 2557876
[TBL] [Abstract][Full Text] [Related]
10. Effect of converting enzyme inhibitors on tissue converting enzyme and angiotensin II: therapeutic implications.
Unger T; Ganten D; Lang RE
Am J Cardiol; 1987 Apr; 59(10):18D-22D. PubMed ID: 3034027
[TBL] [Abstract][Full Text] [Related]
11. [Ramipril and cardiac and renal angiotensin converting enzyme].
Grima M; Stephan D; Welsch C; Coquard C; Barthelmebs M; Imbs JL
Arch Mal Coeur Vaiss; 1995 Feb; 88 Spec No 2():43-8. PubMed ID: 7646311
[TBL] [Abstract][Full Text] [Related]
12. [Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat].
Ingert C; Grima M; Michel B; Barthelmebs M; Imbs JL
Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1135-41. PubMed ID: 9404423
[TBL] [Abstract][Full Text] [Related]
13. Ramipril inhibition of rabbit (Oryctolagus cuniculus) small intestinal brush border membrane angiotensin converting enzyme.
Stevens BR; Phillips MI; Fernandez A
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1988; 91(2):493-7. PubMed ID: 2905962
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of ramipril in renal failure.
Aurell M; Delin K; Herlitz H; Ljungman S; Witte PU; Irmisch R
Am J Cardiol; 1987 Apr; 59(10):65D-69D. PubMed ID: 3034036
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and effects on the renin-angiotensin system of ramipril in elderly patients.
Gilchrist WJ; Beard K; Manhem P; Thomas EM; Robertson JI; Ball SG
Am J Cardiol; 1987 Apr; 59(10):28D-32D. PubMed ID: 3034029
[TBL] [Abstract][Full Text] [Related]
16. [Tissue renin-angiotensin system. Physiology and physiopathological value of their inhibition by ramipril].
Clauser E
Rev Prat; 1990 Jun; 40(18 Suppl):10-5. PubMed ID: 2143594
[TBL] [Abstract][Full Text] [Related]
17. The renin-angiotensin system and ramipril, a new converting enzyme inhibitor.
Vasmant D; Bender N
J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S46-52. PubMed ID: 2483429
[TBL] [Abstract][Full Text] [Related]
18. Loop diuretics combined with an ACE inhibitor for treatment of hypertension: a study with furosemide, piretanide, and ramipril in spontaneously hypertensive rats.
Becker RH; Baldes L; Treudler M
J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S35-9. PubMed ID: 2474099
[TBL] [Abstract][Full Text] [Related]
19. Twenty-four hour changes in active and inactive renin after various oral doses of the converting enzyme inhibitor ramipril (HOE498) in normal man.
Malatino LS; Manhem P; Ball SG; Leckie BJ; Morton JJ; Murray GD; Robertson JI
J Clin Hypertens; 1986 Sep; 2(3):231-7. PubMed ID: 3023553
[TBL] [Abstract][Full Text] [Related]
20. Long-term low-dose angiotensin converting enzyme inhibitor treatment increases vascular cyclic guanosine 3',5'-monophosphate.
Gohlke P; Lamberty V; Kuwer I; Bartenbach S; Schnell A; Linz W; Schölkens BA; Wiemer G; Unger T
Hypertension; 1993 Nov; 22(5):682-7. PubMed ID: 8225528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
